A Clinical trial to study the effect of bhallatakadi modaka in the patient with haemorrhoids

Clinical study of bhallatakadi modaka in the management of pittaja arshas (haemorrhoids) - pittaja arshas

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011609

Enrollment

Registered

2018-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- pittaja arshas -Haemorrhoids

Interventions

Intervention1: Bhallatakadi modaka: Bhallatakadi modaka given 3 gm twice daily for 15 days with lukewarm milk after meals Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with the symptoms of PittajaArshas, in addition to the signs and symptoms of Haemorrhoids, between 18-60years of age

Exclusion criteria

Exclusion criteria: The Arshas developed due to portal hypertension and constipation or due to secondary factors, The patients suffering from external Hemorrhoids and conditions like thrombosis, Ulcerative & strangulated Hemorrhoids

Design outcomes

Primary

Measure	Time frame
1. Subjective Parameters: 1. Assessment of pain 2. Bleeding per rectum 3. Swelling 4. Mass per rectum 5. Mucous discharge Objective Parameters: 1. Proctoscopic evaluation of the pile mass is done for: 1. Position 2. Degree of Hemorrhoids 3. Number 4. Bleeding Point Timepoint: 4	—

Secondary

Measure	Time frame
Improvement in the hemoglobin levelTimepoint: 4	—

Countries

India

Contacts

Public ContactDr Prasanna Narasimha Rao

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

santoshs.satyarthi@gmail.com8793820710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026